The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1214
August 1, 2005
View Complete Issue         Table of Contents 2019 
Atypical Antipsychotics in the Elderly
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Atypical Antipsychotics in the Elderly
August 1, 2005 (Issue: 1214)
The FDA has reported that 5106 elderly patients with dementia treated with atypical (second generation) antipsychotics in 17 randomized controlled trials had a higher mortality rate (4.5% vs. 2.6%) than those receiving placebo. Most of the deaths...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Atypical Antipsychotics in the Elderly
Article code: 1214a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.